RESUMEN
The eponym Niemann-Pick disease (NPD) refers to a group of patients who present with varying degrees of lipid storage and foam cell infiltration in tissues, as well as overlapping clinical features including hepatosplenomegaly, pulmonary insufficiency and/or central nervous system (CNS) involvement. Due to the pioneering work of Roscoe Brady and co-workers, we now know that there are two distinct metabolic abnormalities that account for NPD. The first is due to the deficient activity of the enzyme acid sphingomyelinase (ASM; "types A & B" NPD), and the second is due to defective function in cholesterol transport ("type C" NPD). Herein only types A and B NPD will be discussed. Type A NPD patients exhibit hepatosplenomegaly in infancy and profound CNS involvement. They rarely survive beyond 2-3years of age. Type B patients also have hepatosplenomegaly and pathologic alterations of their lungs, but there are usually no CNS signs. The age of onset and rate of disease progression varies greatly among type B patients, and they frequently live into adulthood. Intermediate patients also have been reported with mild to moderate neurological findings. All patients with types A and B NPD have mutations in the gene encoding ASM (SMPD1), and thus the disease is more accurately referred to as ASM deficiency (ASMD). Herein we will review the clinical, pathological, biochemical, and genetic findings in types A and B NPD, and emphasize the seminal contributions of Dr. Brady to this disease. We will also discuss the current status of therapy for this disorder.
Asunto(s)
Colesterol/metabolismo , Enfermedades de Niemann-Pick/clasificación , Esfingomielina Fosfodiesterasa/deficiencia , Edad de Inicio , Animales , Progresión de la Enfermedad , Femenino , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Masculino , Mutación , Enfermedades de Niemann-Pick/genética , Esfingomielina Fosfodiesterasa/genéticaRESUMEN
An unresolved issue about many neurodegenerative diseases is why neurons are particularly sensitive to defects in ubiquitous cellular processes. One example is Niemann Pick type C1, caused by defects in cholesterol trafficking in all cells, but where neurons are preferentially damaged. Understanding this selective failure is limited by the difficulty in obtaining live human neurons from affected patients. To solve this problem, we generated neurons with decreased function of NPC1 from human embryonic stem cells and used them to test the hypothesis that defective cholesterol handling leads to enhanced pathological phenotypes in neurons. We found that human NPC1 neurons have strong spontaneous activation of autophagy, and, contrary to previous reports in patient fibroblasts, a block of autophagic progression leading to defective mitochondrial clearance. Mitochondrial fragmentation is an exceptionally severe phenotype in NPC1 neurons compared with fibroblasts, causing abnormal accumulation of mitochondrial proteins. Contrary to expectation, these abnormal phenotypes were rescued by treatment with the autophagy inhibitor 3-methyladenine and by treatment with the potential therapeutic cyclodextrin, which mobilizes cholesterol from the lysosomal compartment. Our findings suggest that neurons are especially sensitive to lysosomal cholesterol accumulation because of autophagy disruption and accumulation of fragmented mitochondria, thus defining a new route to effective drug development for NPC1 disease.
Asunto(s)
Autofagia , Colesterol/metabolismo , Neuronas/metabolismo , Enfermedades de Niemann-Pick/metabolismo , Adenina/análogos & derivados , Adenina/farmacología , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Diferenciación Celular , Células Cultivadas , Ciclodextrinas/farmacología , Células Madre Embrionarias/metabolismo , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Immunoblotting , Péptidos y Proteínas de Señalización Intracelular , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Microscopía Confocal , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Proteínas Mitocondriales/metabolismo , Células-Madre Neurales/metabolismo , Neuronas/efectos de los fármacos , Neuronas/patología , Proteína Niemann-Pick C1 , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/genética , Interferencia de ARN , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
Types A and B Niemann-Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM). An animal model of NPD has been created by gene targeting. In affected animals, the disease followed a severe, neurodegenerative course and death occurred by eight months of age. Analysis of these animals showed their tissues had no detectable ASM activity, the blood cholesterol levels and sphingomyelin in the liver and brain were elevated, and atrophy of the cerebellum and marked deficiency of Purkinje cells was evident. Microscopic analysis revealed 'NPD cells' in reticuloendothelial organs and characteristic NPD lesions in the brain. Thus, the ASM deficient mice should be of great value for studying the pathogenesis and treatment of NPD, and for investigations into the role of ASM in signal transduction and apoptosis.
Asunto(s)
Enfermedades de Niemann-Pick/enzimología , Enfermedades de Niemann-Pick/genética , Esfingomielina Fosfodiesterasa/deficiencia , Esfingomielina Fosfodiesterasa/genética , Animales , Secuencia de Bases , Encéfalo/patología , Ceramidas/metabolismo , Colesterol/sangre , Cartilla de ADN/genética , Modelos Animales de Enfermedad , Femenino , Marcación de Gen , Humanos , Masculino , Ratones , Ratones Noqueados , Datos de Secuencia Molecular , Enfermedades de Niemann-Pick/clasificación , Linaje , Embarazo , Transducción de SeñalRESUMEN
To date, several genetic variants that lead to a deficiency of chitotriosidase activity have been described. The duplication of 24 bp (dup24bp) in exon 10 of the CHIT1 gene, which causes a complete loss of enzymatic activity of the gene product, is the most common among the European population. The aim of the study was to evaluate the possibility of using chitotriosidase activity as an additional biomarker in diagnosis of lysosomal storage diseases (LSDs) in Ukraine, to determine this parameter in blood plasma of the patients with various lysosomal diseases and to assess the effect of the presence of dup24bp in the CHIT1 gene on this parameter. It has been shown that chitotriosidase activity in blood plasma is a convenient additional biochemical marker in the diagnosis of some LSDs, namely Gaucher disease, Niemann-Pick disease A, B, C and GM1-gangliosidosis. Reference ranges of the normal chitotriosidase activity were determined in blood plasma of Ukrainian population and found to be 8.0-53.1 nmol 4-methylumbelliferone/h·ml of plasma. The total allele frequency of the dup24bp in the CHIT1 gene in Ukrainian population was determined, which amounted to 0.26 (323/1244) that is higher than in European population. It was indicated that moleculargenetic screening of dup24bp in the CHIT1 gene is a necessary stage in a protocol for the laboratory diagnosis of Gaucher disease, Niemann-Pick disease A, B, C as well as GM1-gangliosidosis to avoid incorrect diagnosis.
Asunto(s)
Gangliosidosis GM1/genética , Enfermedad de Gaucher/genética , Frecuencia de los Genes , Hexosaminidasas/genética , Enfermedades de Niemann-Pick/genética , Adulto , Alelos , Biomarcadores/metabolismo , Estudios de Casos y Controles , Exones , Femenino , Gangliosidosis GM1/clasificación , Gangliosidosis GM1/diagnóstico , Gangliosidosis GM1/patología , Enfermedad de Gaucher/diagnóstico , Enfermedad de Gaucher/patología , Duplicación de Gen , Expresión Génica , Pruebas Genéticas , Hexosaminidasas/sangre , Hexosaminidasas/deficiencia , Humanos , Himecromona/sangre , Masculino , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/diagnóstico , Enfermedades de Niemann-Pick/patología , UcraniaRESUMEN
The Niemann-Pick group of diseases can be broadly classified into two types based on clinical and biochemical characteristics. Type I is characterized by a primary deficiency of lysosomal sphingomyelinase while Type II may have a defect in the regulation of intracellular cholesterol metabolism. We have studied cholesterol esterification in cultured fibroblasts from patients with two phenotypes of Type II disease: an Acadian population of southwestern Nova Scotia (Canada) with a form of the disease known as Niemann-Pick type D (NPD) and a group of panethnic origin with Niemann-Pick type C (NPC). Addition of whole serum to normal fibroblasts grown initially in lipoprotein-deficient serum caused a rapid (within 6 h) increase in cholesterol esterification, reaching maximum values at around 24 h, while NPC fibroblasts showed little increase (less than 10% of normal). In contrast, cholesterol esterification in NPD fibroblasts increased slowly during the first 6-12 h and reached 50% of normal values by 24 h. 25-Hydroxycholesterol, a non-lipoprotein stimulator of cholesterol esterification, caused a similar stimulation of cholesterol esterification in NPC, NPD and normal cells. This was inhibited by addition of serum in mutant but not in normal cells. Within 24 h of serum addition, free cholesterol accumulated in all cell types with NPC greater than NPD greater than normal. These observations indicate that (a) regulation of cholesterol esterification in response to serum lipoproteins (but not 25-hydroxycholesterol) is abnormal in both NPC and NPD fibroblasts, and (b) the biochemical phenotypes of fibroblasts from NPC and NPD patients are distinct.
Asunto(s)
Colesterol/metabolismo , Enfermedades de Niemann-Pick/metabolismo , Células Cultivadas , Esterificación , Fibroblastos/metabolismo , Humanos , Cinética , Enfermedades de Niemann-Pick/clasificaciónRESUMEN
The effects of dimethylsulfoxide (DMSO) on sphingomyelinase activity measured at pH range 3.5-8.0 were examined in normal and Niemann-Pick disease type A, B and C fibroblasts culture. In normal cells, a minor activity was observed at pH 7.5, which was 3- to 4-fold lower than a major one at pH 5.0. Both activities at pH 5.0 and 7.5 were Mg2+-independent and localized to lysosomes. Niemann-Pick type C cells had 30-50% residual sphingomyelinase activity at both pH 5.0 and 7.5, as compared to normal control cells, whereas type A and B cells exhibited virtually no activity over the entire pH range examined. Treatment with 2% DMSO caused a marked increase in sphingomyelinase activities at pH 5.0 and 7.5 in normal and Niemann-Pick disease type C cells, while in type A and B cells, both activities remained virtually unchanged after DMSO treatment. The increase in sphingomyelinase activity at pH 5.0 induced in normal cells by DMSO resulted in an increase in the Vmax without a substantial change in the Km and was inhibited by the simultaneous addition of 10 micrograms/ml of cycloheximide. By comparison, a less than 2-fold increase in other lysosomal hydrolase activities was observed after DMSO treatment in all cell lines examined.
Asunto(s)
Dimetilsulfóxido/farmacología , Fibroblastos/enzimología , Enfermedades de Niemann-Pick/enzimología , Hidrolasas Diéster Fosfóricas/metabolismo , Esfingomielina Fosfodiesterasa/metabolismo , Línea Celular , Cicloheximida/farmacología , Activación Enzimática/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Fibroblastos/patología , Humanos , Concentración de Iones de Hidrógeno , Líquido Intracelular/efectos de los fármacos , Líquido Intracelular/enzimología , Lisosomas/efectos de los fármacos , Lisosomas/enzimología , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/patología , Esfingomielina Fosfodiesterasa/antagonistas & inhibidoresRESUMEN
Two sisters with Niemann-Pick disease type C were examined: the brain in one sister, who had died, was examined, and eye movements in the other, surviving sister were recorded. Ocular motor recordings showed marked slowing of vertical saccades with relative sparing of horizontal saccades, pursuit, and the vestibulo-ocular reflex. Neuropathological findings included glial fibrillary lesions in the area of the posterior commissure and neuronal loss in the rostral interstitial nucleus of the MLF with preservation of the interstitial nucleus of Cajal and ocular motor complex. These neuropathologic findings correlate well with our current understanding of the anatomy and physiology of the supranuclear control of vertical gaze.
Asunto(s)
Tronco Encefálico/patología , Enfermedades de Niemann-Pick/fisiopatología , Nervio Oculomotor/patología , Adulto , Ataxia/etiología , Encéfalo/patología , Movimientos Oculares/fisiología , Femenino , Humanos , Imagen por Resonancia Magnética , Neuronas Motoras/patología , Neuronas Motoras/fisiología , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/patología , HermanosRESUMEN
Analysis of the neurologic symptomatology in 22 patients with Niemann-Pick disease type C revealed 3 phenotypes: (1) an early-onset, rapidly progressive form associated with severe hepatic dysfunction and psychomotor delay during infancy and later with supranuclear vertical gaze paresis, ataxia, marked spasticity, and dementia; (2) a delayed-onset, slowly progressive form heralded by the appearance, usually in early childhood, of mild intellectual impairment, supranuclear vertical gaze paresis, and ataxia, and later associated with dementia and, variably, seizures and extrapyramidal deficits; (3) a late-onset slowly progressive form distinguished from the 2nd pattern by later age of onset (adolescence or adulthood) and a much slower rate of progression. The existence of the 1st and 2nd phenotypes within the same sibship suggests that they are variant expressions of the same clinicopathologic disorder. Niemann-Pick disease type C should be considered not only in infants and children who present with organomegaly and a progressive neurodegenerative course, but also in adolescents and adults who have insidiously progressive neurologic dysfunction and only slight organomegaly. Associated with the disease is a marked deficiency in the ability of cultured fibroblasts to esterify exogenously supplied cholesterol. Assay of this deficiency is particularly useful for confirming the diagnosis in patients with atypical presentation.
Asunto(s)
Enfermedades de Niemann-Pick/clasificación , Adolescente , Adulto , Factores de Edad , Niño , Preescolar , Electroencefalografía , Femenino , Humanos , Lactante , Masculino , Enfermedades de Niemann-Pick/diagnóstico , Enfermedades de Niemann-Pick/genética , FenotipoRESUMEN
Analysis of the temporal sequence of neurologic events, neurophysiologic abnormalities, and longevity in 36 Niemann-Pick type C patients revealed two clinical subgroups with five stages of severity within each group. Patients with a preschool onset (group I; n = 18) had a higher mortality than did patients with a school-age onset (group II; n = 18). An asymptomatic phase (stage 0) was defined by biochemical and histopathologic evidence of disease. The initial manifestations of stage 1 were a movement disorder (group I) and cognitive difficulties (group II) accompanied by impaired vertical saccadic eye movements and abnormal acoustic reflexes. Stage 2 was characterized by the sequential occurrence of vertical supranuclear gaze palsy (VSGP), cognitive difficulties, and dysarthria in group I and a movement disorder, VSGP, and dysarthria in group II. Pyramidal tract signs and abnormal brainstem auditory evoked responses defined stage 3 in both groups. Stage 4 culminated in a nonambulant, vegetative state.
Asunto(s)
Enfermedades de Niemann-Pick/clasificación , Adolescente , Adulto , Niño , Preescolar , Ésteres del Colesterol/metabolismo , Electroencefalografía , Potenciales Evocados/fisiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Enfermedades de Niemann-Pick/mortalidad , Enfermedades de Niemann-Pick/fisiopatología , Factores de Riesgo , Análisis de SupervivenciaRESUMEN
A 51 year old man presented in 1969 with slowly progressive cerebellar ataxia of unknown origin. He was admitted to hospital aged 68 after a fall, and a ruptured spleen was removed at laparotomy. Histological analysis of the spleen suggested Niemann-Pick disease, which was subsequently confirmed. He deteriorated and died of bronchopneumonia shortly afterwards: subdural haemorrhage with storage material in neurones was found at necropsy. This late onset case of Niemann-Pick disease with neurovisceral storage is unusual and may represent a variant.
Asunto(s)
Enfermedades de Niemann-Pick/clasificación , Factores de Edad , Encéfalo/patología , Humanos , Lípidos/análisis , Masculino , Persona de Mediana Edad , Enfermedades de Niemann-Pick/patología , Bazo/patologíaRESUMEN
The immunoblotting technique was used to identify sphingomyelinase protein in samples of tissue and urine after subjection to polyacrylamide-gel electrophoresis in the presence of sodium dodecyl sulphate. In a sphingomyelinase preparation purified from control urine a prominent band was seen with an Mr of 28 000 Da. Glycoprotein fractions from urine and placenta, a membrane extract from spleen, and a partially purified sphingomyelinase preparation from placenta contained the 28 000-Da band plus additional, higher-Mr bands. The 28 000-Da band was detectable in urine from a patient with Niemann-Pick disease type C, but not in urine from patients with Niemann-Pick disease types A and B. It is concluded that sphingomyelinase is composed of at least one polypeptide with an Mr of 28 000 Da and that this polypeptide is deficient in the urine of patients with Niemann-Pick disease types A and B.
Asunto(s)
Enfermedades de Niemann-Pick/enzimología , Hidrolasas Diéster Fosfóricas/deficiencia , Esfingomielina Fosfodiesterasa/deficiencia , Humanos , Lisosomas/enzimología , Peso Molecular , Enfermedades de Niemann-Pick/clasificación , Esfingomielina Fosfodiesterasa/inmunología , Esfingomielina Fosfodiesterasa/orinaRESUMEN
Patients grouped into categories termed type C Niemann-Pick disease and the Nova Scotia isolate called type D Niemann-Pick disease are characterized by mild to moderate hepatosplenomegaly, sea-blue histiocytes in the bone marrow, supranuclear gaze paresis in the vertical plane, slowly progressing ataxia, and mental deterioration. These signs are caused by abnormal intracellular cholesterol homeostasis. Cholesterol that enters cells from the circulation through the LDL receptor is not processed in a timely, normal manner by cells in parenchymal organs and the CNS. It therefore accumulates in toxic quantities as unesterified cholesterol causing cellular and tissue damage. Knowledge of the primary, consistent disturbance in cholesterol disposition has led to the development of tests to diagnose patients, identify heterozygotes, and assure the prenatal detection of these disorders. Therapeutic strategies include reduction of dietary cholesterol, apheresis techniques designed to reduce LDL cholesterol available to cells, and reduction of formation of LDL and increase of synthesis of HDL to lower cellular uptake of cholesterol and enhance egress of this lipid from intracellular storage sites. The development of procedures that block cholesterol formation but do not up-regulate LDL receptors on plasma cell membranes is considered to be highly important for the therapy of types C and D Niemann-Pick disease.
Asunto(s)
Enfermedades de Niemann-Pick/genética , Adulto , Médula Ósea/patología , Encéfalo/patología , Niño , Colesterol/metabolismo , Humanos , Hígado/patología , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/patología , Receptores de LDL/genéticaRESUMEN
Clinical and biochemical studies were performed on 6 cases of type C Niemann-Pick disease. Neurological symptoms started in early infancy in 3 cases, and in childhood in the other 3 cases. However, no clear discriminations were possible with regard to neurological and general somatic manifestations between these two groups. All patients showed normal or slightly low sphingomyelinase and beta-glucosidase activities in fibroblasts, and a defect of esterification of exogenous cholesterol. The extent of these abnormalities was not correlated with the clinical course or severity of this disease.
Asunto(s)
Colesterol/metabolismo , Enfermedades de Niemann-Pick/clasificación , Niño , Preescolar , Femenino , Fibroblastos/enzimología , Glucuronidasa/metabolismo , Humanos , Lactante , Masculino , Enfermedades de Niemann-Pick/metabolismo , Esfingomielina Fosfodiesterasa/metabolismo , beta-Galactosidasa/metabolismo , beta-Glucosidasa/metabolismo , beta-N-Acetilhexosaminidasas/metabolismoRESUMEN
Cultured fibroblasts from patients with Niemann-Pick disease type C (NP-C) are characterized by lysosomal accumulation of unesterified cholesterol and a defect in intracellular trafficking of cholesterol. We have found the accumulation of GM2 ganglioside in NP-C fibroblasts [Yano T, Taniguchi M, Akaboshi S, Vanier MT, Tai T, Sakuraba H, et al. Proc Japan Acad 1996;72B:214-219]. In this communication we show that several inhibitors known to inhibit intracellular cholesterol transport, progesterone, imipramine and KN-62, elicit accumulation of not only unesterified cholesterol but also GM2 ganglioside. This finding suggests that intracellular transport of cholesterol may be coupled with that of GM2 ganglioside. The accumulation of free cholesterol and GM2 ganglioside may be a clue for understanding the basic defect of NP-C. Recently NPC1 gene is found by the positional cloning. The mechanism of accumulating of GM2 ganglioside should be further investigated by studying of the functions of NPC1 gene.
Asunto(s)
Colesterol/metabolismo , Gangliósido G(M2)/metabolismo , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/metabolismo , Progesterona/farmacología , 1-(5-Isoquinolinesulfonil)-2-Metilpiperazina/análogos & derivados , 1-(5-Isoquinolinesulfonil)-2-Metilpiperazina/farmacología , Animales , Transporte Biológico/efectos de los fármacos , Células Cultivadas , Fibroblastos/metabolismo , Técnica del Anticuerpo Fluorescente , Humanos , Imipramina/farmacología , Enfermedades de Niemann-Pick/patología , RatasRESUMEN
It is estimated that 70-100 children suffering from a lysosomal storage disease are born in Poland every year. From 1975 to 1993, the activity of various lysosomal enzymes was determined in the leukocytes, cultured skin fibroblasts, or hair roots from 5,594 patients, mainly children, in whom the diagnosis of a lipidosis was suspected. In that material 162 cases of a lipidosis were diagnosed. Metachromatic leukodystrophy seems to be the most frequent of the lipidoses; GM1 gangliosidosis is more frequent than GM2 gangliosidosis and Gaucher and Niemann-Pick diseases appear to be almost as frequent as the former.
Asunto(s)
Lipidosis/epidemiología , Enfermedades por Almacenamiento Lisosomal/epidemiología , Adolescente , Niño , Preescolar , Estudios Transversales , Femenino , Enfermedad de Gaucher/clasificación , Enfermedad de Gaucher/epidemiología , Enfermedad de Gaucher/genética , Humanos , Incidencia , Lactante , Recién Nacido , Leucodistrofia Metacromática/clasificación , Leucodistrofia Metacromática/epidemiología , Leucodistrofia Metacromática/genética , Lipidosis/clasificación , Lipidosis/genética , Enfermedades por Almacenamiento Lisosomal/clasificación , Enfermedades por Almacenamiento Lisosomal/genética , Masculino , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/epidemiología , Enfermedades de Niemann-Pick/genética , Polonia/epidemiologíaRESUMEN
Analysis of recent literature on Niemann-Pick disease type C (NPC) reveals a broad clinical spectrum with diverse neurological manifestations. Diagnosis and assessment are discussed. We present a case with symptomatology that is in concordance with a specific phenotype. The major clinical features are highlighted in a review of recently published cases. NPC could be underdiagnosed and we argue that in the work-up of progressive neurological disorders NPC should be seriously considered, at all ages, whenever there is any combination of visceromegaly, psychomotor deterioration, ataxia, vertical gaze disturbances or developmental delay. The Filipine staining of fibroblasts is a helpful asset in the diagnostic process, to be concluded with the detection of defective intracellular cholesterol esterification.
Asunto(s)
Encefalopatías Metabólicas/diagnóstico , Enfermedades de Niemann-Pick/diagnóstico , Adolescente , Atrofia , Médula Ósea/patología , Encéfalo/patología , Encefalopatías Metabólicas/clasificación , Encefalopatías Metabólicas/genética , Encefalopatías Metabólicas/patología , Femenino , Fibroblastos/patología , Humanos , Imagen por Resonancia Magnética , Examen Neurológico , Pruebas Neuropsicológicas , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/genética , Enfermedades de Niemann-Pick/patología , Tomografía Computarizada por Rayos XRESUMEN
Niemann-Pick disease type C (NP-C) is an autosomal recessive lysosomal lipid storage disorder of unknown etiology. Diagnosis of NP-C is based on characteristic clinical findings and reduced fibroblast esterification of LDL-derived cholesterol. We describe three patients who demonstrate the NP-C spectrum of clinical heterogeneity in age of onset, presenting signs, pattern of organ system involvement, and natural history. In addition, electron microscopic analysis of skin biopsy specimens from these patients revealed marked variability in the extent and cellular distribution of intralysosomal storage and was suggestive of the correct diagnosis in only one case. These cases demonstrate both the limitations of electron microscopy for diagnosis of NP-C and the marked clinical variability in patients with this disorder. Practical clinical guidelines for appropriate suspicion of NP-C are presented.
Asunto(s)
Enfermedades de Niemann-Pick/fisiopatología , Adolescente , Preescolar , Femenino , Fibroblastos/patología , Humanos , Recién Nacido , Masculino , Microscopía Electrónica , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/metabolismo , Piel/patologíaRESUMEN
Variations of platelet aggregation and plasma levels of clotting factors V, IX, XI, and XII were studied in 5 patients with Niemann-Pick disease type Is in the course of a 3-year study of treatment with periodic subcutaneous infusions of amniotic epithelial cells. Before commencement of treatment, the concentrations of these factors were found to be abnormal in four of five patients. It was possible to complete the study protocol in only two patients. Platelet aggregation and plasma levels of V, IX, XI, and XII clotting factors had been determined before each epithelial amniotic cells implantation and after 24, 48, and 72 hours. In both patients the aggregation test and the plasma levels of coagulation factors V, IX, XI, and XII were below the normal values of reference. Results showed that the epithelial amniotic cells treatment normalized platelet aggregation after each implantation in the two studied patients, both in terms of intensity of response (increase in light transmission after addition of adenosine diphosphate up to 350%) and in terms of obtaining an irreversible aggregation with 3 and 8 microM of adenosine diphosphate. The data related to clotting factors showed an increase of these concentrations up to 60% and some of these concentrations normalized completely.
Asunto(s)
Amnios/citología , Factores de Coagulación Sanguínea/análisis , Trasplante de Células , Enfermedades de Niemann-Pick/sangre , Enfermedades de Niemann-Pick/terapia , Agregación Plaquetaria , Adolescente , Células Cultivadas , Células Epiteliales , Femenino , Humanos , Masculino , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/fisiopatología , Esfingomielina Fosfodiesterasa/deficiencia , Esfingomielina Fosfodiesterasa/metabolismoRESUMEN
Neurolipidoses may present as psychiatric illness or dementia which may be isolated for a long time without neurological manifestations. Thus the relation with a metabolic disease may be difficult to establish. In this survey, we wish to present our clinical and biological experience in relation with lysosomal or peroxisomal disorders giving rise to neurolipidoses, a review of the literature, as well as the elements which allow to present a diagnostic strategy. We report mainly on metachromatic leukodystrophy, GM2 gangliosidosis, Fabry's disease, Niemann-Pick type C, Kufs disease, adrenoleukodystrophy, cerebro-tendinous xanthomatosis. Psychiatric symptoms may overshadow subtle signs of cognitive and motor dysfunction. Careful and persistent neurodiagnostic evaluation must be performed even in cases when CT and MRI scans are considered normal. Resistance to psychotropic drugs may be an element of orientation. The biological diagnosis is mainly biochemical. Although most of the genes involved have been cloned, many of the mutations are private, except for metachromatic leukodystrophy for which specific mutations may be related to adult cases and either with predominantly motor or predominantly cognitive and psychiatric manifestations. This review discusses also other metabolic diseases which may present as isolated or predominant cognitive and psychiatric manifestations.
Asunto(s)
Trastornos del Conocimiento/etiología , Trastornos Mentales/etiología , Enfermedades de Niemann-Pick/complicaciones , Adolescente , Adulto , Trastornos del Conocimiento/diagnóstico , Femenino , Humanos , Masculino , Trastornos Mentales/diagnóstico , Enfermedades de Niemann-Pick/clasificación , Enfermedades de Niemann-Pick/genética , Índice de Severidad de la EnfermedadRESUMEN
Niemann-Pick group of diseases are rare autosomal recessive disorders of lysosomal enzymes. These are divisible into six types depending on clinical and biochemical features. On the basis of sphingomyelinase assay in five cases of Niemann-Pick disease, three cases were classified as type IA, one as type IS and one as type IIS. Their clinicopathological profiles are compared with 17 cases reported previously from India.